Change in serum albumin concentration is inversely and independently associated with risk of incident metabolic syndrome

Metabolism: Clinical and Experimental

Volumn 65, Issue 11, 2016, Pages 1629-1635

  Jin, Sang Man ^a   Hong, Yong Joo ^a   Jee, Jae Hwan ^a   Bae, Ji Cheol ^a   Hur, Kyu Yeon ^a   Lee, Moon Kyu ^a   Kim, Jae Hyeon ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

Author keywords

Albumin; Change; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; SERUM ALBUMIN;

ADULT; ARTICLE; COHORT ANALYSIS; FEMALE; HAZARD RATIO; HUMAN; LONGITUDINAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; BODY MASS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; INCIDENCE; RISK; SOUTH KOREA; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK; SERUM ALBUMIN; YOUNG ADULT;

EID: 84989906152     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2016.08.006     Document Type: Article

References (29)

1. [1] Kim, KJ, Lee, BW, The roles of glycated albumin as intermediate glycation index and pathogenic protein. Diabetes Metab J 36 (2012), 98–107.
2. [2] Bourdon, E, Blache, D, The importance of proteins in defense against oxidation. Antioxid Redox Signal 3 (2001), 293–311.
3. [3] Roche, M, Rondeau, P, Singh, NR, Tarnus, E, Bourdon, E, The antioxidant properties of serum albumin. FEBS Lett 582 (2008), 1783–1787.
4. [4] Halliwell, B, Albumin-an important extracellular antioxidant?. Biochem Pharmacol 37 (1988), 569–571.
5. [5] Djousse, L, Rothman, KJ, Cupples, LA, Levy, D, Ellison, RC, Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 106 (2002), 2919–2924.
6. [6] Kuller, LH, Eichner, JE, Orchard, TJ, Grandits, GA, McCallum, L, Tracy, RP, The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 134 (1991), 1266–1277.
7. [7] Nelson, JJ, Liao, D, Sharrett, AR, Folsom, AR, Chambless, LE, Shahar, E, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol 151 (2000), 468–477.
8. [8] Phillips, A, Shaper, AG, Whincup, PH, Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 2 (1989), 1434–1436.
9. [9] Schalk, BW, Visser, M, Bremmer, MA, Penninx, BW, Bouter, LM, Deeg, DJ, Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam. Am J Epidemiol 164 (2006), 969–977.
10. [10] Anraku, M, Elucidation of the mechanism responsible for the oxidation of serum albumin and its application in treating oxidative stress-related diseases. Yakugaku Zasshi 134 (2014), 973–979.
11. [11] Anraku, M, Chuang, VT, Maruyama, T, Otagiri, M, Redox properties of serum albumin. Biochim Biophys Acta 1830 (2013), 5465–5472.
12. [12] Era, S, Kuwata, K, Imai, H, Nakamura, K, Hayashi, T, Sogami, M, Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1247 (1995), 12–16.
13. [13] Halliwell, B, Gutteridge, JM, The antioxidants of human extracellular fluids. Arch Biochem Biophys 280 (1990), 1–8.
14. [14] Nagumo, K, Tanaka, M, Chuang, VT, Setoyama, H, Watanabe, H, Yamada, N, et al. Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases. PLoS One, 9, 2014, e85216.
15. [15] Bologa, RM, Levine, DM, Parker, TS, Cheigh, JS, Serur, D, Stenzel, KH, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 32 (1998), 107–114.
16. [16] Gabay, C, Kushner, I, Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 340 (1999), 448–454.
17. [17] Danesh, J, Muir, J, Wong, YK, Ward, M, Gallimore, JR, Pepys, MB, Risk factors for coronary heart disease and acute-phase proteins. A population-based study. Eur Heart J 20 (1999), 954–959.
18. [18] Ishizaka, N, Ishizaka, Y, Nagai, R, Toda, E, Hashimoto, H, Yamakado, M, Association between serum albumin, carotid atherosclerosis, and metabolic syndrome in Japanese individuals. Atherosclerosis 193 (2007), 373–379.
19. [19] Kadono, M, Hasegawa, G, Shigeta, M, Nakazawa, A, Ueda, M, Yamazaki, M, et al. Serum albumin levels predict vascular dysfunction with paradoxical pathogenesis in healthy individuals. Atherosclerosis 209 (2010), 266–270.
20. [20] Saito, I, Yonemasu, K, Inami, F, Association of body mass index, body fat, and weight gain with inflammation markers among rural residents in Japan. Circ J 67 (2003), 323–329.
21. [21] Han, CY, Roles of reactive oxygen species on insulin resistance in adipose tissue. Diabetes Metab J 40 (2016), 272–279.
22. [22] Xu, H, Barnes, GT, Yang, Q, Tan, G, Yang, D, Chou, CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112 (2003), 1821–1830.
23. [23] Furukawa, S, Fujita, T, Shimabukuro, M, Iwaki, M, Yamada, Y, Nakajima, Y, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114 (2004), 1752–1761.
24. [24] Houstis, N, Rosen, ED, Lander, ES, Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440 (2006), 944–948.
25. [25] Alberti, KG, Eckel, RH, Grundy, SM, Zimmet, PZ, Cleeman, JI, Donato, KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120 (2009), 1640–1645.
26. [26] Matthews, DR, Hosker, JP, Rudenski, AS, Naylor, BA, Treacher, DF, Turner, RC, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985), 412–419.
27. [27] Levey, AS, Bosch, JP, Lewis, JB, Greene, T, Rogers, N, Roth, D, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999), 461–470.
28. [28] Yu, TY, Jee, JH, Bae, JC, Jin, SM, Baek, JH, Lee, MK, et al. Serum uric acid: A strong and independent predictor of metabolic syndrome after adjusting for body composition. Metabolism 65 (2016), 432–440.
29. [29] Lee, MJ, Jung, CH, Kang, YM, Hwang, JY, Jang, JE, Leem, J, et al. Serum bilirubin as a predictor of incident metabolic syndrome: a 4-year retrospective longitudinal study of 6205 initially healthy Korean men. Diabetes Metab 40 (2014), 305–309.